Quick Answer
ADC Therapeutics SA reported Total Assets of $323.15 million for the year ending 2025.
- ADC Therapeutics SA showed an increase of +0.4% in Total Assets from 2024 to 2025.
- This data is from ADC Therapeutics SA's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $307.97 million | Q2 2024: $371.78 million | Q3 2024: $349.08 million | Q1 2025: $272.54 million | Q2 2025: $321.56 million | Q3 2025: $289.76 million.
- Over the full 7 years of available data (2019 to 2025), ADC Therapeutics SA's Total Assets has grown by 134.7%.
- Historical annual values: Fiscal year 2025: $323.15 million | Fiscal year 2024: $321.98 million | Fiscal year 2023: $354.78 million | Fiscal year 2022: $490.86 million | Fiscal year 2021: $617.97 million | Fiscal year 2020: $513.69 million | Fiscal year 2019: $137.68 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: